DFFN

Diffusion Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0589 -4.53% 1.2411 11:38:24
Open Price Low Price High Price Close Price Prev Close
1.34 1.22 1.35 1.30
more quote information »

Recent News

Date Time Source Heading
1/26/20218:30IHNWFeaturedUS NUCLEAR FUTURISTIC STAR TREK ROCKET ENGINES COULD BE HERE SOONER THAN YOU THINK
1/11/202107:30GLOBEDiffusion Pharmaceuticals to Participate in H.C. Wainwright..
1/08/202116:08EDGARCurrent Report Filing (8-k)
12/14/202011:33EDGARCurrent Report Filing (8-k)
11/18/202008:34EDGARStatement of Changes in Beneficial Ownership (4)
11/12/202016:58EDGARCurrent Report Filing (8-k)
11/12/202016:02GLOBEDiffusion Pharmaceuticals Reports Third Quarter 2020..
10/21/202019:50EDGARInitial Statement of Beneficial Ownership (3)
10/20/202017:31EDGARCurrent Report Filing (8-k)
10/19/202008:00GLOBEDiffusion Pharmaceuticals Appoints Dr. Chris Galloway as..
10/14/202019:40EDGARStatement of Changes in Beneficial Ownership (4)
10/14/202019:28EDGARInitial Statement of Beneficial Ownership (3)
10/09/202016:17EDGARCurrent Report Filing (8-k)
10/02/202016:17EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
9/25/202016:07EDGARSecurities Registration Statement (simplified Form) (s-3)
9/24/202008:00GLOBEDiffusion Pharmaceuticals Strengthens Management Team with..
9/15/202014:51EDGARCurrent Report Filing (8-k)
9/11/202018:57EDGARStatement of Changes in Beneficial Ownership (4)
9/11/202008:30GLOBEDiffusion Pharmaceuticals to Present at the H.C. Wainwright..
9/10/202016:40EDGARCurrent Report Filing (8-k)
9/10/202008:00GLOBEDiffusion Pharmaceuticals Doses First Two Patients with TSC..
9/09/202009:30EDGARCurrent Report Filing (8-k)
9/08/202016:02GLOBEDiffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi..
9/04/202016:01EDGARCurrent Report Filing (8-k)
9/01/202016:02GLOBEDiffusion Pharmaceuticals Appoints Jane H. Hollingsworth to..
8/10/202017:01EDGARCurrent Report Filing (8-k)
8/10/202008:00GLOBEDiffusion Pharmaceuticals Reports Second Quarter 2020..
8/07/202016:12EDGARQuarterly Report (10-q)
7/29/202008:14EDGARCurrent Report Filing (8-k)
7/27/202008:00GLOBEDiffusion Pharmaceuticals Receives FDA Guidance for..
7/07/202016:39EDGARCurrent Report Filing (8-k)
7/07/202008:00GLOBEDiffusion Pharmaceuticals Files IND for International Phase..
6/18/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202016:38EDGARCurrent Report Filing (8-k)
6/12/202012:19EDGARCurrent Report Filing (8-k)
6/11/202008:00GLOBEDiffusion Pharmaceuticals Files Clinical Trial Application..
6/11/202006:00EDGARNotice of Effectiveness (effect)
6/08/202016:49EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/03/202017:26EDGARSecurities Registration Statement (s-1/a)
6/01/202016:41EDGARCurrent Report Filing (8-k)
6/01/202008:00GLOBEDiffusion Pharmaceuticals Regains Compliance with NASDAQ..
5/29/202017:23EDGARSecurities Registration Statement (s-1)
5/27/202016:58EDGARSmall Company Offering and Sale of Securities Without..
5/26/202016:46EDGARCurrent Report Filing (8-k)
5/26/202008:00GLOBEDiffusion Pharmaceuticals Receives Accelerated FDA Response..
5/20/202017:28EDGARCurrent Report Filing (8-k)
5/20/202017:23EDGARCurrent Report Filing (8-k)
5/20/202013:00GLOBEDiffusion Pharmaceuticals Inc. Announces Closing of $12.0..
5/20/202008:00GLOBEDiffusion Pharmaceuticals Expands Clinical Trial Program of..
5/19/202017:30EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
See more news about this stock »


Your Recent History
NASDAQ
DFFN
Diffusion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.